-
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
Monday, January 6, 2025 - 3:53pm | 676Read More...JPMorgan has reset the valuation for Viking Therapeutics Inc. (NASDAQ:VKTX) and Structure Therapeutics Inc. (NASDAQ:GPCR). Analyst Hardik Parikh cites several reasons for recovery, including pathways for strategic partnership with pharma, some clinical trial data points and additional clarity on...
